Cardiac Transplantation in Patients With Hypertrophic Cardiomyopathy

被引:47
|
作者
Kato, Tomoko S. [1 ]
Takayama, Hiroo [2 ]
Yoshizawa, Saeko [3 ]
Marboe, Charles [3 ]
Schulze, P. Christian [1 ]
Farr, Maryjane [1 ]
Naka, Yoshifumi [2 ]
Mancini, Donna [1 ]
Maurer, Mathew S. [1 ]
机构
[1] Columbia Univ, Dept Med, Div Cardiol, Med Ctr, New York, NY 10027 USA
[2] Columbia Univ, Dept Surg, Div Cardiothorac Surg, Med Ctr, New York, NY USA
[3] Columbia Univ, Dept Pathol, Med Ctr, New York, NY USA
来源
AMERICAN JOURNAL OF CARDIOLOGY | 2012年 / 110卷 / 04期
关键词
MUSCLE CELL DISORGANIZATION; LEFT-VENTRICULAR HYPERTROPHY; HEART-TRANSPLANTATION; CLINICAL-SIGNIFICANCE; ATHLETES HEART; SURVIVAL; PREVALENCE; INFECTION; DIAGNOSIS; FEATURES;
D O I
10.1016/j.amjcard.2012.04.030
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cardiac transplantation is a treatment option for patients with hypertrophic cardiomyopathy (HC) who developed refractory heart failure and/or intractable arrhythmia. However, the pretransplant characteristics and post-transplant prognosis for patients with nondilated idiopathic HC has not yet fully elucidated. Therefore, we retrospectively reviewed 813 consecutive transplant recipients undergoing cardiac transplantation at Columbia University Medical Center from 1999 to 2010 and compared the clinical course of 41 patients with idiopathic HC with that of 373 patients with ischemic heart disease and 398 patients with other heart disease. The patients with HC were younger than those with ischemic heart disease (47.8 +/- 14.0 vs 57.1 +/- 9.4 years; p <0.0001). The proportion of patients undergoing ventricular assist devise surgery for bridge-to-transplant was lower in patients with HC than in those with ischemic heart disease or other heart disease (14.6% vs 31.1% vs 35.7%, all p <0.01). The post-transplant survival of those with HC was better than that for those with ischemic heart disease (90.1% vs 85.8% and 83.9% vs 67.1% at 1 and 5 years, respectively; p = 0.0359), although it was not significantly different from those with other heart disease. Proportional hazards analysis revealed that the subjects with HC had reduced post-transplant mortality (hazard ratio 0.4760, 95% confidential interval 0.1889 to 0.9762; p = 0.042) on univariate, but not multivariate, analysis. Most patients with HC had nondilated left ventricles (left ventricular end-diastolic dimension <= 55 mm; n = 27), and post-transplant survival did not differ from that for those with dilated left ventricles (left ventricular end-diastolic dimension >55 mm; n = 14). In conclusion, the post-transplant survival of those with HC did not differ from those of the subjects who underwent transplant for other non-HC indications. (C) 2012 Elsevier Inc. All rights reserved. (Am J Cardiol 2012;110:568-574)
引用
收藏
页码:568 / 574
页数:7
相关论文
共 50 条
  • [31] Cardiac troponin T mutations in Chinese patients with hypertrophic cardiomyopathy
    吴恒芳
    杨笛
    万文辉
    卞智萍
    徐晋丹
    马文珠
    张寄南
    中华医学杂志(英文版), 2004, (06) : 144 - 146
  • [32] Heartbeat: sudden cardiac death risk in patients with hypertrophic cardiomyopathy
    Otto, Catherine M.
    HEART, 2023, 109 (10) : 725 - 727
  • [33] Cardiac troponin T mutations in Chinese patients with hypertrophic cardiomyopathy
    吴恒芳
    杨笛
    万文辉
    卞智萍
    徐晋丹
    马文珠
    张寄南
    Chinese Medical Journal, 2004, (06)
  • [34] IDENTIFICATION OF CARDIAC AMYLOIDOSIS AMONG A COHORT OF HYPERTROPHIC CARDIOMYOPATHY PATIENTS
    Fatima, Amber
    Maron, Martin
    Maron, Barry
    Rowin, Ethan
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (09) : 1009 - 1009
  • [35] Assessment of dynamic cardiac repolarization and contractility in patients with hypertrophic cardiomyopathy
    Radbill, Andrew E.
    Lei, Lucy Y.
    Paranjape, Sachin Y.
    Blackwell, Daniel J.
    Abraham, Robert L.
    Chew, Derek S.
    Raj, Satish R.
    Knollmann, Bjorn C.
    PLOS ONE, 2021, 16 (02):
  • [36] Sudden cardiac arrest in patients with hypertrophic cardiomyopathy: Are there electrocardiographic predictors?
    Gill, Jashan
    Munshi, Rezwan
    Varghese, Jobin
    Spooner, Michael T.
    Olshansky, Brian
    JOURNAL OF ELECTROCARDIOLOGY, 2025, 90
  • [37] CARDIAC MAGNETIC RESONANCE IN HYPERTROPHIC CARDIOMYOPATHY: APPLICATION TO PEDIATRIC PATIENTS
    Slesnick, Tim
    Parks, W. James
    Fischbach, Peter
    Frias, Patrick
    Campbell, Robert
    Demo, Erin
    Sallee, Denver
    Strieper, Margaret
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 59 (13) : E1095 - E1095
  • [38] Implication of sleep apnea for cardiac remodeling in patients with hypertrophic cardiomyopathy
    Xu, Haobo
    Wang, Wei
    Yuan, Jiansong
    Guo, Chao
    Hu, Fenghuan
    Yang, Weixian
    Luo, Xiaoliang
    Cui, Jingang
    Qiao, Shubin
    Wang, Juan
    SLEEP MEDICINE, 2024, 116 : 115 - 122
  • [39] CARDIAC REHABILITATION EFFECTS ON THE PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY: A SYSTEMATIC REVIEW
    Chichagi, Fatemeh
    Hakim, Diaa El din A.
    Shirsalimi, Niyousha
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 514 - 514
  • [40] Cardiac Transplantation Outcomes in Patients with Amyloid Cardiomyopathy
    Ohiomoba, Ramael
    Ezema, Ashley
    Youmans, Quentin R.
    Anderson, Allen S.
    Jackson, Kamari
    Mandieka, Edwin
    Pham, Duc T.
    Rich, Jonathan D.
    Yancy, Clyde W.
    Okwuosa, Ike S.
    JOURNAL OF CARDIAC FAILURE, 2019, 25 (08) : S181 - S181